United States · FDA National Drug Code directory
IRBESARTAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-448_45662cb2-60ef-45d5-80a2-fd60ee7250bd
- Product NDC
- 59746-448
- Form
- TABLET
- Composition / generic term
- IRBESARTAN
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150224
- Source listing expiry
- 20271231
Source-listed ingredients
- IRBESARTAN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (59746-448-05) · 59746-448-05
- 30 TABLET in 1 BOTTLE (59746-448-30) · 59746-448-30
- 90 TABLET in 1 BOTTLE (59746-448-90) · 59746-448-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →